Willem Oosterlinck
- Urology top 0.1%
- Urological Disorders and Treatments 16
- Surgery top 0.2%
- Bladder and Urothelial Cancer Treatments 39
- Urinary and Genital Oncology Studies 32
- Oncology top 2%
- Cancer Research top 5%
-
- Renal cell carcinoma treatment 3
-
- Infectious Disease Case Reports and Treatments 3
-
- Cancer Research and Treatments 2
-
- Polyamine Metabolism and Applications 2
- Epigenetics and DNA Methylation 2
- Co-authors
- Richard SylvesterAdrian P.M. van der MeijdenJ. Alfred WitjesC BouffiouxEero KaasinenDonald W. W. NewlingKarl‐Heinz KurthLouis Denis
- Partner nations
- BelgiumSpainNetherlands
In The Last Decade
Willem Oosterlinck
39 papers receiving 6.7k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Urology 2.1k
- Surgery 6.1k
- Oncology 1.1k
- Cancer Research 367
- Pulmonary and Respiratory Medicine 788
Countries citing papers authored by Willem Oosterlinck
This map shows the geographic impact of Willem Oosterlinck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Willem Oosterlinck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Willem Oosterlinck more than expected).
Fields of papers citing papers by Willem Oosterlinck
This network shows the impact of papers produced by Willem Oosterlinck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Willem Oosterlinck. The network helps show where Willem Oosterlinck may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Willem Oosterlinck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 5 | |
| 2 | 2018 | 8 | |
| 3 | 2017 | 2 | |
| 4 | 2015 | 42 | |
| 5 | 2015 | 5 | |
| 6 | 2013 | 244 | |
| 7 | 2012 | 110 | |
| 8 | 2011 | 293 | |
| 9 | EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Updatebreakdown → | 2011 | 785 |
| 10 | 2010 | 42 | |
| 11 | 2009 | 14 | |
| 12 | 2008 | 127 | |
| 13 | Diagnosis and treatment of superficial bladder tumours | 2006 | 0 |
| 14 | Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trialsbreakdown → | 2006 | 2101 |
| 15 | 2006 | 2 | |
| 16 | 2002 | 360 | |
| 17 | 2001 | 2 | |
| 18 | 1995 | 19 | |
| 19 | 1993 | 280 | |
| 20 | Prognostic factors in superficial bladder tumors | 1992 | 40 |
About Willem Oosterlinck
Willem Oosterlinck is a scholar working on Urology, Surgery and Complementary and Manual Therapy, having authored 41 papers that have together received 6.8k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (39 papers), Urinary and Genital Oncology Studies (32 papers), Urological Disorders and Treatments (16 papers), Renal cell carcinoma treatment (3 papers), Infectious Disease Case Reports and Treatments (3 papers), Cancer Research and Treatments (2 papers), Polyamine Metabolism and Applications (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Urology (2.1k citations), Surgery (6.1k citations) and Oncology (1.1k citations). Willem Oosterlinck has collaborated with scholars based in Belgium, Spain and Netherlands. Frequent co-authors include Richard Sylvester, Adrian P.M. van der Meijden, J. Alfred Witjes, C Bouffioux, Eero Kaasinen, Donald W. W. Newling, Karl‐Heinz Kurth, Louis Denis, Marko Babjuk and J. Palou-Redorta. Their work appears in journals such as Cancer, The Journal of Urology and European Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.